Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Altamira Therapeutics Ltd
CYTOF
Healthcare
Biotechnology
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery...
platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CYTOF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Nov 17, 2023 3:16pm
Barrons had it at 235$ next year
Wow
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Nov 17, 2023 3:09pm
Wednesday had the intuition to buy
But did not listen
RVV Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
posted Jan 09, 2025 9:00am by
Revive Therapeutics Ltd
-
|
Over the next few weeks data will be collected and analysed for effect size. Should the data show significant effects, Revive and the DRDC will discuss on the future development path. The results from this research study, if promising, will determine further studies to facilitate FDA and Health Canada approvals for the use of Bucillamine in nerve agents or organophosphate pesticide poisoning and explore its potential for traumatic brain injury caused by concussive or explosive forces and viral infections. ...read more
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Nov 17, 2023 3:08pm
Last time saw such volume was tempest
Jump in at .29
(2)
•••
stamps56
X
View Profile
View Bullboard History
Comment by
stamps56
on Nov 17, 2023 11:08am
RE:CYTO.....I can't trade today.....grrrrrrrr
which bank
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 17, 2023 10:56am
CYTO.....I can't trade today.....grrrrrrrr
My discount Bank Brokers website is facked up....again!!!!! This happens far too often Time for a change Enjoy reading this while it last....SH Admin Cop will remove this real quick ; ) Urinates
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 17, 2023 10:52am
CYTO..better late than never ; ) early a.m runner on NR
Altamira Therapeutics Announces Partial Spin-Off of (globenewswire.com)
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2023 12:25pm
CYTO.....thru support at $1.82 next support is .....
$1.63 You've all been had again !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2023 12:18pm
CYTO..... All the early a.m Chasers are getting their
Heads handed to them in a basket What a deal !!!!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 22, 2023 8:47am
New Press Release - Altamira Therapeutics' SemaPhore Delivery Platform Shows Significant Synergis-tic Effects of ZBTB46 mRNA with PD1 Immunotherapy in Control of Tumor Growth in Animal Model
HAMILTON, BERMUDA, March 22, 2023 (GLOBE NEWSWIRE) -- Preprint of results from animal study shows restriction of tumor growth in mice treated with ZBTB46 mRNA nanoparticles based on Altamira’s SemaPhore™ delivery technologyNanoparticle treatment combined with immune checkpoint inhibitor...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 15, 2023 8:48am
New Press Release - Altamira Therapeutics' SemaPhore RNA Delivery Platform Drives Effective Treatment of Osteoarthritis with mRNA in Animal Model
Data to be presented at Osteoarthritis Research Society International World Congress in Denver March 17-20, 2023Animal study shows effective attenuation of osteoarthritis progression and functional improvement in mice treated with DNMT3B mRNA nanoparticles based on Altamira's SemaPhore™ delivery...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 3:27pm
TRKA..... Nothing but "sideways action"
No position Going skiing....have a great weekend. Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 2:25pm
CYTO......5 more cents and this be red...LoL
Shoulda held ny short position Coulda been 100% up and almost that on the way down I'm not greedy ; )
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 03, 2023 2:06pm
RE:CYTO ..... go green to red move LoL
Only 15 cents to go ...before this goes red..... what a game!!
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 1:44pm
CYTO ..... go green to red move LoL
No position
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 03, 2023 1:26pm
CYTO..... Thos is so-o-o typical of a NASDAQ runner
Not always of course..... but you have to be wary...stops save portfolios ; ) Here is what I am saying..... https://invst.ly/-g2gl
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Global Tungsten Market Overview and Supply Security
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine